-
1
المؤلفون: Klaas van der Linde, Michelle S G Sikkens, Yvonne J B van Megen, M. W. M. D. Lutgens, Joanne P J Bloemsaat-Minekus, Corinne M Stoop, Andrea Van Der Meulen, Halil Akol, Marieke Pierik, Johan Kuijvenhoven, Ids J. Klompmaker, Gerard Dijkstra
المساهمون: Interne Geneeskunde, MUMC+: MA Maag Darm Lever (9), RS: NUTRIM - R2 - Liver and digestive health
المصدر: Crohn's & Colitis 360, 4(3):001. Oxford University Press
Crohn's & Colitis 360, 4(3). OXFORD UNIV PRESSمصطلحات موضوعية: medicine.medical_specialty, business.industry, Gastroenterology, Biosimilar, EFFICACY, medicine.disease, THERAPY, Inflammatory bowel disease, CROHNS-DISEASE, Infliximab, quality of life, Quality of life, inflammatory bowel disease, Internal medicine, END-POINTS, medicine, biosimilar, INHIBITORS, infliximab, business, medicine.drug
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfe906b4eebf52832318eaa05e6cf380
https://doi.org/10.1093/crocol/otab001